Published in Liver Int on April 01, 2008
ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol (2013) 4.36
Review article: coeliac disease, new approaches to therapy. Aliment Pharmacol Ther (2012) 1.04
Hepatic manifestations of celiac disease. Clin Exp Gastroenterol (2010) 0.91
Combination testing for antibodies in the diagnosis of coeliac disease: comparison of multiplex immunoassay and ELISA methods. Aliment Pharmacol Ther (2008) 0.86
Autoantibodies in primary sclerosing cholangitis. World J Gastroenterol (2008) 0.81
Liver involvement in celiac disease. Minerva Med (2008) 0.81
Clinical utility of serologic testing for celiac disease in ontario: an evidence-based analysis. Ont Health Technol Assess Ser (2010) 0.79
Celiac sprue: a unique autoimmune disorder. Expert Rev Clin Immunol (2009) 0.78
The role of celiac disease in severity of liver disorders and effect of a gluten free diet on diseases improvement. Hepat Mon (2013) 0.78
Liver involvement in pediatric celiac disease. World J Gastroenterol (2015) 0.77
Celiac disease-related autoantibodies in end-stage autoimmune liver diseases: what is the message? Liver Int (2008) 0.77
Celiac disease markers in patients with liver diseases: a single center large scale screening study. World J Gastroenterol (2012) 0.76
Primary sclerosing cholangitis in patient with celiac disease complicated by cholecystic empyema and acute pancreatitis. G Chir (2014) 0.75
Hepatobiliary disorders in celiac disease: an update. Int J Hepatol (2010) 0.75
Coeliac disease and autoimmune disease-genetic overlap and screening. Nat Rev Gastroenterol Hepatol (2015) 0.75
To screen or not to screen? Celiac antibodies in liver diseases. World J Gastroenterol (2017) 0.75
Association of Autoimmune Hepatitis and Celiac Disease: Role of Gluten-Free Diet in Reversing Liver Dysfunction. J Investig Med High Impact Case Rep (2017) 0.75
Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology (1992) 10.44
Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med (2003) 7.80
Celiac sprue. N Engl J Med (2002) 7.12
American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology (2006) 4.41
The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut (1998) 4.16
Immunosuppressive drugs for kidney transplantation. N Engl J Med (2004) 4.09
The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology (2005) 3.33
Current concepts of celiac disease pathogenesis. Gastroenterology (2000) 3.23
Molecular basis of celiac disease. Annu Rev Immunol (2000) 3.09
Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology (2002) 2.99
HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology (1993) 2.72
Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther (2006) 2.49
HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens (1993) 2.37
Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut (2007) 1.92
Hematologic manifestations of celiac disease. Blood (2006) 1.87
Risk of primary biliary liver cirrhosis in patients with coeliac disease: Danish and Swedish cohort data. Gut (1999) 1.79
Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut (2005) 1.75
Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet. Hepatology (1995) 1.74
HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest (2006) 1.66
HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol (2002) 1.58
Significance of smooth muscle/anti-actin autoantibodies in celiac disease. Acta Gastroenterol Latinoam (2005) 1.42
Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol (2005) 1.37
Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study. Dig Liver Dis (2006) 1.35
Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci (1998) 1.34
Coeliac disease hidden by cryptogenic hypertransaminasaemia. Lancet (1998) 1.33
Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther (2003) 1.28
Chronic unexplained hypertransaminasemia may be caused by occult celiac disease. Hepatology (1999) 1.23
Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases? Transplantation (2005) 1.17
Should adults be screened for celiac disease? What are the benefits and harms of screening? Gastroenterology (2005) 1.10
Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always coeliac disease? Am J Gastroenterol (2005) 1.06
High prevalence of celiac disease in autoimmune hepatitis detected by anti-tissue tranglutaminase autoantibodies. J Clin Lab Anal (2005) 1.03
Immunoglobulin A (IgA) deficiency and alternative celiac disease-associated antibodies in sera submitted to a reference laboratory for endomysial IgA testing. Clin Diagn Lab Immunol (2000) 1.02
Primary sclerosing cholangitis and celiac disease. A novel association. Ann Intern Med (1988) 0.99
Diagnostic criteria for coeliac disease: time for change? Eur J Gastroenterol Hepatol (2005) 0.98
Use of HLA typing in diagnosing celiac disease in patients with type 1 diabetes. Diabetes Care (2005) 0.98
Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association. Aliment Pharmacol Ther (2005) 0.95
[Hepatic damage in celiac disease in children]. Minerva Pediatr (1986) 0.95
High rate of positive anti-tissue transglutaminase antibodies in chronic liver disease. Role of liver decompensation and of the antigen source. Scand J Gastroenterol (2003) 0.94
High prevalence of celiac sprue among patients with primary biliary cirrhosis. J Clin Gastroenterol (1997) 0.92
Systematic review: the liver in coeliac disease. Aliment Pharmacol Ther (2005) 0.91
False positive reactions for IgA and IgG anti-tissue transglutaminase antibodies in liver cirrhosis are common and method-dependent. Clin Chim Acta (2005) 0.87
Primary sclerosing cholangitis with celiac sprue: two cases. J Clin Gastroenterol (1996) 0.79
Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med (2003) 7.80
Multiple common variants for celiac disease influencing immune gene expression. Nat Genet (2010) 6.90
Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med (2008) 6.67
The Oslo definitions for coeliac disease and related terms. Gut (2012) 5.76
Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr (2005) 5.34
The prevalence of celiac disease in the United States. Am J Gastroenterol (2012) 4.77
American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology (2006) 4.41
ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol (2013) 4.36
Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology (2009) 3.73
Transfusion-related acute lung injury in the critically ill: prospective nested case-control study. Am J Respir Crit Care Med (2007) 3.69
Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc (2012) 3.60
A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology (2013) 3.56
The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl (2002) 3.44
MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology (2005) 2.99
Results of the first year of the new liver allocation plan. Liver Transpl (2004) 2.86
Patients with celiac disease are not followed up adequately. Clin Gastroenterol Hepatol (2012) 2.78
Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant (2005) 2.54
The incidence and risk of celiac disease in a healthy US adult population. Am J Gastroenterol (2012) 2.47
Transfusion-related acute lung injury and pulmonary edema in critically ill patients: a retrospective study. Transfusion (2006) 2.45
Evidence-based red cell transfusion in the critically ill: quality improvement using computerized physician order entry. Crit Care Med (2006) 2.44
Lymphocytic duodenosis and the spectrum of celiac disease. Am J Gastroenterol (2009) 2.26
Improving liver allocation: MELD and PELD. Am J Transplant (2004) 2.14
Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients. Chest (2007) 2.11
Increased risk of systemic lupus erythematosus in 29,000 patients with biopsy-verified celiac disease. J Rheumatol (2012) 2.11
Natural history of hepatopulmonary syndrome: Impact of liver transplantation. Hepatology (2005) 2.05
Is it necessary to assess for fat-soluble vitamin deficiencies in pediatric patients with newly diagnosed celiac disease? J Pediatr Gastroenterol Nutr (2014) 2.04
Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity. Am J Gastroenterol (2009) 2.02
Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology (2010) 2.01
A report on the International Transglutaminase Autoantibody Workshop for Celiac Disease. Am J Gastroenterol (2009) 1.94
Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Transplantation (2008) 1.92
Tests of liver injury. Clin Med Res (2004) 1.89
Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol (2010) 1.88
Fresh frozen plasma transfusion in critically ill medical patients with coagulopathy. Crit Care Med (2005) 1.87
Portopulmonary hypertension: Results from a 10-year screening algorithm. Hepatology (2006) 1.87
Hematologic manifestations of celiac disease. Blood (2006) 1.87
Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C. Liver Transpl (2003) 1.86
Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc (2004) 1.85
A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am J Gastroenterol (2004) 1.83
The liver in celiac disease. Hepatology (2007) 1.81
Transfusion from male-only versus female donors in critically ill recipients of high plasma volume components. Crit Care Med (2007) 1.79
Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol (2002) 1.79
Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation (2013) 1.78
Routine duodenal biopsies to exclude celiac disease? Gastrointest Endosc (2003) 1.76
Chronic renal dysfunction late after liver transplantation. Liver Transpl (2002) 1.74
The insensitivity of endoscopic markers in celiac disease. Am J Gastroenterol (2002) 1.70
Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl (2007) 1.69
Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transpl (2009) 1.69
Increasing incidence of celiac disease in a North American population. Am J Gastroenterol (2013) 1.69
Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol (2003) 1.66
Antithymocyte globulin has limited efficacy and substantial toxicity in unselected anemic patients with myelodysplastic syndrome. Blood (2002) 1.64
A prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic strictures. Am J Gastroenterol (2005) 1.64
Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology (2008) 1.63
Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue. Clin Gastroenterol Hepatol (2010) 1.58
Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl (2004) 1.58
MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology (2004) 1.57
Adult intussusception in the last 25 years of modern imaging: is surgery still indicated? J Gastrointest Surg (2011) 1.54
Capsule endoscopy in nonresponsive celiac disease. Gastrointest Endosc (2011) 1.54
Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects. Arch Dermatol (2010) 1.52
Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol (2011) 1.52
Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol (2007) 1.51
Celiac disease. Curr Opin Gastroenterol (2010) 1.51
Hepatopulmonary syndrome: favorable outcomes in the MELD exception era. Hepatology (2013) 1.50
Training in small-bowel capsule endoscopy: assessing and defining competency. Gastrointest Endosc (2013) 1.50
Esophageal function testing with combined multichannel intraluminal impedance and manometry: multicenter study in healthy volunteers. Clin Gastroenterol Hepatol (2003) 1.48
Classification and management of refractory coeliac disease. Gut (2010) 1.48
Pathogen-specific risk of celiac disease following bacterial causes of foodborne illness: a retrospective cohort study. Dig Dis Sci (2013) 1.47
Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am J Transplant (2003) 1.46
Significance of intraepithelial lymphocytosis in small bowel biopsy samples with normal mucosal architecture. Am J Gastroenterol (2003) 1.44
Pregnancy outcome and risk of celiac disease in offspring: a nationwide case-control study. Gastroenterology (2011) 1.44
Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PLoS One (2012) 1.42
Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol (2008) 1.38
MELD and other factors associated with survival after liver transplantation. Am J Transplant (2004) 1.34
Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients. Mayo Clin Proc (2007) 1.34
HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol (2002) 1.30
Overcoming a positive crossmatch in living-donor kidney transplantation. Am J Transplant (2003) 1.29
Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology (2010) 1.29
Ultrasound-assisted percutaneous liver biopsy performed by a physician assistant. Am J Gastroenterol (2002) 1.29
Collagenous gastritis: histopathologic features and association with other gastrointestinal diseases. Am J Surg Pathol (2009) 1.29
Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol (2009) 1.25
Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease. Clin Gastroenterol Hepatol (2008) 1.23
A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J Clin Invest (2004) 1.23
Dermatitis herpetiformis. Int J Dermatol (2003) 1.23
HLA DQ gene dosage and risk and severity of celiac disease. Clin Gastroenterol Hepatol (2007) 1.22
Acute lung injury after blood transfusion in mechanically ventilated patients. Transfusion (2004) 1.20
Hepatitis B vaccine nonresponse and celiac disease. Am J Gastroenterol (2003) 1.20
Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl (2004) 1.19
Gluten-free diet: the medical and nutrition management of celiac disease. Nutr Clin Pract (2006) 1.19
An update in the diagnosis of coeliac disease. Histopathology (2010) 1.18
The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature (2008) 1.16
Variations in presentations of esophageal involvement in lichen planus. Clin Gastroenterol Hepatol (2010) 1.15
Clinical experience in pemphigoid gestationis: report of 10 cases. J Am Acad Dermatol (2006) 1.15
Sensitization to gliadin induces moderate enteropathy and insulitis in nonobese diabetic-DQ8 mice. J Immunol (2011) 1.12
Long-term fracture risk in patients with celiac disease: a population-based study in Olmsted County, Minnesota. Dig Dis Sci (2007) 1.12
Evidence-based evolution of the MELD/PELD liver allocation policy. Liver Transpl (2005) 1.11